Trustees’ Annual Report for the period
From 31 Oct 2021 Period start date To 30 Oct 2022 Period end date
Charity name: Lipodystrophy UK
Charity registration number: 1175462
Objectives and Activities
| SORP reference | ||
|---|---|---|
| Summary of the purposes of the charity as set out in its governing document |
Para 1.17 | The objects of the CIO are: i. To raise awareness of Lipodystrophy conditions, both within the medical profession and the general public; ii. To provide information and support to people with Lipodystrophy and those affected by it; iii. To advocate for excellent care and improved treatment options for people with Lipodystrophy; To encourage research addressing the concerns of people with Lipodystrophy |
| Summary of the main activities in relation to those purposes for the public benefit, in particular, the activities, projects or services identified in the accounts. |
Para 1.17 and 1.19 |
- Patient pathways survey for patients and formal presentation of findings - Patient support activities online - Raising awareness (World Lipodystrophy Day, conferences, publications, social media, focus groups) - Developed a ‘Charity Strategic Plan’ - Fatigue project with PLRH started recruiting patients - New website launched |
| Statement confirming whether the trustees have had regard to the guidance issued by the Charity Commission on public benefit |
Para 1.18 | All trustees have had regard to the Charity Commission’s guidance on public benefit. |
Additional information (optional)
You may choose to include further statements where relevant about:
SORP reference |
||
|---|---|---|
| Policy on grant making | Para 1.38 | Lipodystrophy UK does not have a policy on grant making, since we don’t currently offer grants |
| Policy on social investment | Para 1.38 | Lipodystrophy UK does not have a policy on social investment |
| including program related investment |
||
|---|---|---|
| Contribution made by volunteers |
Para 1.38 | Lipodystrophy UK does not have a policy on contributions made by volunteers |
| Other |
Achievements and Performance
| SORP reference | ||
|---|---|---|
| Summary of the main achievements of the charity, identifying the difference the charity’s work has made to the circumstances of its beneficiaries and any wider benefits to society as a whole. |
Para 1.20 | 1) Ongoing virtual support for community through COVID - live chats, community check-ins, etc. 2) Ongoing awareness activities – World Lipodystrophy Day. Applying for funding to organise a Patient Support Day for WLD 2023 3) Patient Pathways survey launched for patients. Data combined with Clinician data and findings formally presented at the annual ECLip conference 4) New website launched. PO Box set up. 5) Fatigue project (in collaboration with the Patient Lead Research Hub, PLRH, and Addenbrookes Hospital): LiFE study focus group conducted and REC approval received. Patient interviews started 6) FaceBook charity donations/fundraising set up 7) Collaboration with Physicians and Pharma on development of a ‘Lipodystrophy scoring tool’ for clinicians 8) Chair gave several awareness talks at different conferences and participated in focus groups with stakeholders 9) Ongoing relationship with National Centre of Excellence in Lipodystrophy (Addenbrookes Hospital) 10) Ongoing patient representative on ECLip Board (re-elected) 11) Ongoing relationship with the Centre of Appearance Research (CAR) 12) Note: several activities delayed/postponed due to COVID |
Additional information (optional) You may choose to include further statements where relevant about: Ongoing objectives to 1) raise awareness of Lipodystrophy conditions; 2) provide
| Achievements against objectives set |
Para 1.41 | information and support to people affected by Lipodystrophy; advocate for excellent care and improved treatment options; encourage research addressing the concerns of people with Lipodystrophy |
|---|---|---|
| Performance of fundraising activities against objectives set |
Para 1.41 | N/A |
| Investment performance against objectives |
Para 1.41 | N/A |
| Other |
Financial Review
| Financial Review | ||
|---|---|---|
| Review of the charity’s financial position at the end of the period |
Para 1.21 | Low fundraising income, although sufficient to cover charity expenditure |
| Statement explaining the policy for holding reserves stating why they are held |
Para 1.22 | Lipodystrophy UK does not have a reserves policy |
| Amount of reserves held | Para 1.22 | N/A |
| Reasons for holding zero reserves |
Para 1.22 | N/A |
| Details of fund materially in deficit |
Para 1.24 | N/A |
| Explanation of any uncertainties about the charity continuing as a going concern |
Para 1.23 | N/A |
| Additional information (optional) You may choose to include further statements where relevant about: |
Additional information (optional) You may choose to include further statements where relevant about: |
Additional information (optional) You may choose to include further statements where relevant about: |
|---|---|---|
| The charity’s principal sources of funds (including any fundraising) |
Para 1.47 | Funds exclusively from fundraising activities |
| Investment policy and objectives including any social investment policy adopted |
Para 1.46 | Lipodystrophy UK does not have an investments policy |
| A description of the principal risks facing the charity |
Para 1.46 | More fundraising activities will be needed to fund more ambitious projects in the future. Actively recruiting a volunteer Fundraising Officer (although little interest in the role so far). |
| Other |
Structure, Governance and Management
| Description of charity’s trusts: |
||
|---|---|---|
| Type of governing document (trust deed, royal charter) |
Para 1.25 | Constitution |
| How is the charity constituted? (e.g unincorporated association, CIO) |
Para 1.25 | Charitable Incorporated Organisation |
| Trustee selection methods including details of any constitutional provisions e.g. election to post or name of any person or body entitled to appoint one or more trustees |
Para 1.25 | Apart from the first charity trustees, every trustee must be appointed by a resolution passed at a properly convened meeting of the charity trustees |
Additional information (optional)
You may choose to include further statements where relevant about:
Policies and procedures adopted for the induction and training of trustees |
Para 1.51 |
N/A |
|---|---|---|
| The charity’s organisational structure and any wider network with which the charity works |
Para 1.51 | N/A |
| Relationship with any related parties |
Para 1.51 | Working in partnership with The Centre for Appearance Research (CAR) as a member of the Appearance Collective (AC) - supporting people living with visible differences. |
| Other |
Reference and Administrative details
| Charity name | Lipodystrophy UK |
|---|---|
| Other name the charity uses | LDUK-although almost phased out |
| Registered charity number | 1175462 |
| Charity’s principal address | 29 Collington Way, Kingston Bagpuize, Abingdon OX13 5GP |
Names of the charity trustees who manage the charity
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 |
Trustee name | Office (if any) | Dates acted if not for whole year |
Name of person (or body) entitled to appoint trustee (ifany) |
|---|---|---|---|---|
| Rebecca Sanders | Chair | N/A | Rebecca Sanders(Founder) | |
| Rachel Sanders | Treasurer | N/A | Rebecca Sanders(Founder) | |
| BeckySmith | N/A | N/A | Board majorityvote | |
| Siobhan Dunn | N/A | N/A | Board majorityvote | |
| Claire Adams | N/A | N/A | Board majorityvote | |
– Corporate trustees names of the directors at the date the report was approved Director name N/A
Name of trustees holding title to property belonging to the charity
| Trustee name | Dates acted if not for whole year | |
|---|---|---|
| N/A | ||
Funds held as custodian trustees on behalf of others
Description of the assets N/A held in this capacity Name and objects of the N/A charity on whose behalf the assets are held and how this falls within the custodian charity’s objects Details of arrangements for N/A safe custody and segregation of such assets from the charity’s own assets
Additional information (optional)
Names and addresses of advisers (Optional information)
| Type of adviser |
Name Address |
Name Address |
|---|---|---|
| N/A | ||
Name of chief executive or names of senior staff members (Optional information)
N/A
Exemptions from disclosure
Reason for non-disclosure of key personnel details
N/A
Other optional information
Declarations
The trustees declare that they have approved the trustees’ report above.
Signed on behalf of the charity’s trustees
Signature(s)
Full name(s) Rebecca Sanders
Position (eg Secretary, Chair Chair, etc)
Date
31/08/2023
| Lipodystrophy UK |
Lipodystrophy UK |
Lipodystrophy UK |
Lipodystrophy UK |
CC16a | |
|---|---|---|---|---|---|
| For the period from |
Period start date Oct-21 |
To | |||
| Section A Receipts and payments | |||||
| A1 Receipts Donations 918 - - - - - - - 918 - - Sub total - Total receipts 918 A3 Payments Insurance 169 Invoices 1,318 - - - - - - - Sub total 1,487 - - Sub total - Total payments 1,487 Net of receipts/(payments) - 569 A5 Transfers between funds - A6 Cash funds last year end 7,387 Cash funds this year end 6,818 Unrestricted funds to the nearest £ Sub total(Gross income for AR) A2 Asset and investment sales, (see table). A4 Asset and investment purchases, (see table) |
to the nearest £ Restricted funds |
to the nearest £ Endowment funds |
Total funds to the nearest £ |
Last year to the nearest £ |
|
| - - - - - - - - - |
- - - - - - - - - |
918 - - - - - - - 918 |
- | ||
| - | |||||
| - | |||||
| - | |||||
| - | |||||
| - | |||||
| - | |||||
| - | |||||
| - | |||||
| - - - |
- - - |
- - - |
|||
| - | |||||
| - | |||||
| - | - | 918 | - | ||
| - - - - - - - - - - |
- - - - - - - - - - |
169 1,318 - - - - - - - 1,487 |
- | ||
| - | |||||
| - | |||||
| - | |||||
| - | |||||
| - | |||||
| - | |||||
| - | |||||
| - | |||||
| - | |||||
| - - - |
- - - |
- - - |
|||
| - | |||||
| - | - | 1,487 | - | ||
| - - - - |
- - - - |
- 569 - 7,387 6,818 |
- | ||
| - | |||||
| - | |||||
| - |
Section B Statement of assets and liabilities at the end of the period
| Categories B1 Cash funds B2 Other monetary assets B3 Investment assets B5 Liabilities B4 Assets retained for the charity’s own use Signed by one or two trustees on behalf of all the trustees |
Details Bank account Details Details Details Details Signature Total cash funds (agree balances with receipts and payments account(s)) |
to nearest £ to nearest £ 6,818 - - - - - 6,818 - OK OK to nearest £ to nearest £ - - - - - - - - - - - - Cost (optional) - - - - - Cost (optional) - - - - - - - - - - - - - - Print Name REBECCA SANDERS Unrestricted funds Restricted funds Unrestricted funds Restricted funds Fund to which asset belongs Fund to which asset belongs Fund to which liability relates Amount due (optional) |
to nearest £ Endowment funds |
|---|---|---|---|
| - | |||
| - | |||
| - | |||
| - | |||
| OK | |||
| to nearest £ Endowment funds |
|||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| Current value (optional) |
|||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| Current value (optional) |
|||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| When due (optional) |
|||
| Date of approval |
|||
| REBECCA SANDERS | 8/31/2023 | ||